Mirum Pharmaceuticals financials at a glance

+ Portfolio

The revenue of Mirum Pharmaceuticals is reported as 0.18637 billion Dollars in the fiscal year 2023. The earnings were -3.94 Dollars per share in 2023, which was 1.99 higher than 2022. And about -0.04343 billion Dollars are reported as free cash flow in the financials of Mirum Pharmaceuticals 2023. No dividends were paid to the shareholders of the Mirum Pharmaceuticals stock NasdaqGM:MIRM in the financial year 2023.

$186.37M

Revenue

$-3.94

Earnings Per Share

76.11%

Gross Margin %

$-86.50M

Free Cash Flow

Revenue

186.37

Earnings Per Share

-3.94

Gross Margin %

76.11

Free Cash Flow

-86.50

Financials

Year	Year	TTM	2023	2022	2021	2020	2019
Rev.	Revenue	N/A	$186.37M	$77.06M	$19.14M	$0.00M	$0.00M
GM %	Gross Margin %	81.68%	76.11%	83.94%	90.06%	0.00%	0.00%
OM	Operating Margin	-76.51%	-57.22%	-,170.28%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-4.29	$-3.94	$-4.02	$-6.31	$-4.09	$-4.58
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	-0.00%	-0.00%	0	-0.00%	-0.00%
Sha.	Shares	N/AM	46.62M	37.95M	31.73M	30.42M	24.97M
OCF	Operating Cash Flow	N/A	$-43.43M	$-,120.14M	$-,132.76M	$-89.01M	$-39.36M
FCF	Free Cash Flow	N/A	$-86.50M	$-,120.41M	$-,132.78M	$-88.85M	$-39.64M
FCFS	Free Cash Flow Per Share	$-2.70	$0.00	$-3.56	$-5.01	$-3.54	$-3.45

Mirum Pharmaceuticals financials at a glance

Financials

Discover